INTEGRATED SITE OPERATION
FAST ACTIVATION
RELIABLE ENROLLMENT
ENHANCED STUDY CONDUCT
Profound Research presents an integrated site network comprising over 25 sites with an extensive roster of 700+ physicians, including numerous board-certified specialists. This network grants access to a diverse and expansive pool of over 750,000 patients, spanning a comprehensive spectrum of therapeutic areas such as neurology, dermatology, rheumatology, oncology, cardiovascular, primary care, endocrinology, and vaccines.
Profound provides our sites a centralized hub for key activities crucial to efficient feasibility, budgeting, contracting, quality assurance, regulatory compliance, and study management. These essential functions are supported by a sophisticated technology stack that incorporates CTMS, eReg, eSource, QMS/LMS, and robust training modules. This technological foundation underscores our unwavering commitment to patient safety, principal investigator oversight, and the delivery of high-quality data.
Profound Research provides a best-in-class suite of technology solutions which enable access, transparency, standardization, and efficient processes across our network.
Dedicated resources facilitate detailed review of study protocols to provide data-driven enrollment commitments through centralized EMR access and streamlined site communication, resulting in industry-leading turnaround timelines.
Profound reduces friction and delays in budget and CTA execution through dedicated resources, robust processes, and a commitment to accelerating timelines while maintaining quality.
Profound's eRegulatory platform and centralized regulatory team manages study start-up activities resulting in expedited study initiation while reducing site burden during this critical time in the study lifecycle.
Our quality team leverages an industry-leading quality management system to deploy training, processes, and internal auditing within a continuous process improvement culture.